NEURAXIS, INC. Fair Value Adjustment of Warrants
NEURAXIS, INC. (NRXS) reported Fair Value Adjustment of Warrants of -$2.45 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-11
- NEURAXIS, INC. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$2.45K, a 2157.98% decline year-over-year.
- NEURAXIS, INC. fair value adjustment of warrants for the quarter ending 2026-03-31 was $31.51K.
- NEURAXIS, INC. fair value adjustment of warrants for the quarter ending 2025-12-31 was $7.61K.
- NEURAXIS, INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was $1.74K, a 74.13% decline year-over-year.
- NEURAXIS, INC. fair value adjustment of warrants for fiscal 2025 was $7.63K, a 711.26% increase from fiscal 2024.
- NEURAXIS, INC. fair value adjustment of warrants for fiscal 2024 was $941.00.
- NEURAXIS, INC. fair value adjustment of warrants for fiscal 2023 was -$844.85K.
- NEURAXIS, INC. fair value adjustment of warrants for fiscal 2022 was -$606.05K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.45K 10-Q · filed 2026-08-11 | $29.06K 10-Q · filed 2026-08-11 | $36.66K derived: sum of 3 quarters · filed 2026-08-11 | $38.40K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $31.51K 10-Q · filed 2026-05-12 | $39.11K derived: sum of 2 quarters · filed 2026-05-12 | $40.85K derived: sum of 3 quarters · filed 2026-05-12 | $40.97K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $7.61K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $9.35K derived: sum of 2 quarters · filed 2026-03-19 | $9.46K derived: sum of 3 quarters · filed 2026-08-11 | $7.63K 10-K · filed 2026-03-19 |
| 2025-09-30 | $1.74K 10-Q · filed 2025-11-10 | $1.86K derived: sum of 2 quarters · filed 2026-08-11 | $28.00 10-Q · filed 2025-11-10 | -$7.46K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $119.00 10-Q · filed 2026-08-11 | -$1.71K 10-Q · filed 2026-08-11 | -$9.21K derived: sum of 3 quarters · filed 2026-08-11 | -$2.48K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$1.83K 10-Q · filed 2026-05-12 | -$9.32K derived: sum of 2 quarters · filed 2026-05-12 | -$2.60K derived: sum of 3 quarters · filed 2026-05-12 | -$10.17K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$7.49K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$767.00 derived: sum of 2 quarters · filed 2026-03-19 | -$8.34K derived: sum of 3 quarters · filed 2026-03-19 | $941.00 10-K · filed 2026-03-19 |
| 2024-09-30 | $6.73K 10-Q · filed 2025-11-10 | -$850.00 derived: sum of 2 quarters · filed 2025-11-10 | $8.43K 10-Q · filed 2025-11-10 | -$44.81K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$7.58K 10-Q · filed 2025-08-12 | $1.71K 10-Q · filed 2025-08-12 | -$51.54K derived: sum of 3 quarters · filed 2025-08-12 | -$644.39K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $9.28K 10-Q · filed 2025-05-12 | -$43.96K derived: sum of 2 quarters · filed 2025-05-12 | -$636.81K derived: sum of 3 quarters · filed 2025-05-12 | -$600.76K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$53.24K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$646.10K derived: sum of 2 quarters · filed 2025-03-20 | -$610.05K derived: sum of 3 quarters · filed 2025-03-20 | -$844.85K 10-K · filed 2025-03-20 |
| 2023-09-30 | -$592.85K 10-Q · filed 2024-11-12 | -$556.80K derived: sum of 2 quarters · filed 2024-11-12 | -$791.61K 10-Q · filed 2024-11-12 | -$2.06M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $36.05K 10-Q · filed 2024-08-09 | -$198.76K 10-Q · filed 2024-08-09 | -$1.46M derived: sum of 3 quarters · filed 2024-08-09 | -$1.37M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | -$234.81K 10-Q · filed 2024-05-20 | -$1.50M derived: sum of 2 quarters · filed 2024-05-20 | -$1.41M derived: sum of 3 quarters · filed 2024-05-20 | -$1.47M derived: sum of 4 quarters · filed 2024-05-20 |
| 2022-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$1.18M derived: sum of 2 quarters · filed 2024-04-16 | -$1.24M derived: sum of 3 quarters · filed 2024-04-16 | -$606.05K 10-K · filed 2024-04-16 |
| 2022-09-30 | $90.63K 10-Q · filed 2023-11-20 | $29.11K derived: sum of 2 quarters · filed 2023-11-20 | $660.19K 10-Q · filed 2023-11-20 | |
| 2022-06-30 | -$61.52K 10-Q · filed 2023-09-22 | $569.56K 10-Q · filed 2023-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |